Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Medication Department, Zhuji People's Hospital of Zhejiang Province, Zhuji, 311800, China.
Acta Pharmacol Sin. 2021 Dec;42(12):1951-1969. doi: 10.1038/s41401-021-00620-9. Epub 2021 Mar 9.
Cisplatin is a clinically advanced and highly effective anticancer drug used in the treatment of a wide variety of malignancies, such as head and neck, lung, testis, ovary, breast cancer, etc. However, it has only a limited use in clinical practice due to its severe adverse effects, particularly nephrotoxicity; 20%-35% of patients develop acute kidney injury (AKI) after cisplatin administration. The nephrotoxic effect of cisplatin is cumulative and dose dependent and often necessitates dose reduction or withdrawal. Recurrent episodes of AKI result in impaired renal tubular function and acute renal failure, chronic kidney disease, uremia, and hypertensive nephropathy. The pathophysiology of cisplatin-induced AKI involves proximal tubular injury, apoptosis, oxidative stress, inflammation, and vascular injury in the kidneys. At present, there are no effective drugs or methods for cisplatin-induced kidney injury. Recent in vitro and in vivo studies show that numerous natural products (flavonoids, saponins, alkaloids, polysaccharide, phenylpropanoids, etc.) have specific antioxidant, anti-inflammatory, and anti-apoptotic properties that regulate the pathways associated with cisplatin-induced kidney damage. In this review we describe the molecular mechanisms of cisplatin-induced nephrotoxicity and summarize recent findings in the field of natural products that undermine these mechanisms to protect against cisplatin-induced kidney damage and provide potential strategies for AKI treatment.
顺铂是一种临床应用广泛且高效的抗癌药物,可用于治疗多种恶性肿瘤,如头颈部、肺部、睾丸、卵巢、乳腺癌等。然而,由于其严重的不良反应,特别是肾毒性,限制了其在临床实践中的应用;接受顺铂治疗的患者中有 20%-35%会发生急性肾损伤(AKI)。顺铂的肾毒性是累积性和剂量依赖性的,通常需要减少剂量或停药。AKI 的反复发作会导致肾小管功能受损和急性肾衰竭、慢性肾脏病、尿毒症和高血压性肾病。顺铂诱导的 AKI 的病理生理学涉及肾脏近端小管损伤、细胞凋亡、氧化应激、炎症和血管损伤。目前,对于顺铂引起的肾损伤尚无有效的药物或方法。最近的体外和体内研究表明,许多天然产物(黄酮类、皂苷类、生物碱、多糖、苯丙素等)具有特定的抗氧化、抗炎和抗凋亡特性,可调节与顺铂诱导的肾损伤相关的途径。本综述描述了顺铂诱导肾毒性的分子机制,并总结了天然产物在这一领域的最新研究进展,这些研究进展破坏了这些机制,可预防顺铂引起的肾损伤,并为 AKI 的治疗提供潜在策略。